Q2 2025 Surgical Science Sweden AB Earnings Call Transcript
Key Points
- Surgical Science Sweden AB (SUSRF) achieved several important milestones during the quarter, which are expected to positively impact future quarters.
- The company saw a 22% growth in sales in Europe, indicating strong market development in that region.
- The integration of Intelligent Ultrasound proceeded according to plan, realizing expected cost synergies.
- Development revenues grew significantly by 172%, driven by a major order from a Southeast Asian Ministry of Defense.
- The launch of the Robotics Express product received positive initial customer feedback, indicating potential future sales growth.
- Sales decreased by 2% compared to the same quarter last year, primarily due to a weaker macro-economic climate in key markets.
- Currency effects negatively impacted results by approximately SEK24 million.
- The US market faced continued pressure on procurement budgets, leading to a 12% contraction in sales for educational products.
- License revenues were weaker than expected, partly due to longer development times and regulatory approvals for robotics customers.
- Gross margins declined to 65% from 68% in the previous year, affected by a negative revenue mix and lower simulator sales.
Hi everyone and welcome to this quarter two presentation for Surgical Science. My name is Tom Englund, CEO of Surgical Science, and with me today I have Anna Ahlberg, our company CFO. We will use our time together today to first present the report and then we will take questions from the audience.
Despite a strong Q1 and start of the year, we saw a more negative financial development during the second quarter, primarily driven by a weaker macro-economic climate in some of our key markets. Sales was SEK209 million or 2% decrease versus the same quarter last year. Sales grew by 4% or however, in local currencies. The quarter also saw a significant impact from currency effects, affecting the result negatively by around SEK24 million.
Despite the financial headwinds during the quarter, our company maintained a high execution pace and achieved several important milestones, many of which will have positive impact already in the next few quarters. I want to present the most important highlights and results of the business during
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
